Skip to main content
Log in

Superovulation with a high gonadotropin dose for in vitro fertilization: Is it effective?

  • Clinical Assisted Reproduction
  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript

Abstract

Purpose

Our purpose was to investigate the effect on the ovarian response of increasing the gonadotropin dose.

Methods

We analyzed retrospectively the in vitro fertilization data for patients who had two cycles of treatment, with a higher dose in cycle 2. The patients were stratified according to age, ovarian response, and gonadotropin dose in the first cycle. The main outcome measure was the number of follicles, eggs, and embryos and the peak estradiol (E2) level.

Results

The study included 244 patients. Patients in both age groups (n = 118, - <33 years; n = 126, > 33 years), low (n = 66) and intermediate (n = 145) responders, and patients who received < 225 IU folliclestimulating hormone (n = 175) in cycle I had a better response in cycle 2. However, the high responders (n = 33) and those who received 225 or 300 IU folliclestimulating hormone (n = 69) in cycle I showed a similar response in both cycles, except for a significantly higher E2 level in cycle 2.

Conclusions

Our results indicate that exceeding a daily dose of 300 IU is unrewarding.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Lauffer N, DeCherney AH, Haseltine FP, Dumolin JC: The use of high-dose human menopausal gonadotrophin in an in vitro fertilisation program. Fertil Steril 1982:38:734–741

    Google Scholar 

  2. Jones HW, Jr, Jones GS, Andrews MC, Acosta A, Bundren C, Garcia J, Sandow B, Veek L, Wilkes C, Witmyer J, Wortham JE, Wright G: The program for in vitro fertilisation at Norfolk. Fertil Steril 1982:38:14–21

    PubMed  Google Scholar 

  3. Land JA, Yarmolinskaya MI, Dumoulin JC.M, Evans JH: Highdose human menopausal gonadotrophin stimulation in poor responders does not improve the in vitro fertilization outcome. Fertil Steril 1996:65:961–965

    PubMed  CAS  Google Scholar 

  4. Lockwood GM, Pinkerton SM, and Barlow DH: A prospective randomized single-blind comparative trial of nafarelin acetate with buserelin in long-protocol gonadotrophin-releasing hormone analogue controlled in-vitro fertilization cycles. Hum Reprod 1995; 10:293–298

    PubMed  CAS  Google Scholar 

  5. Gougeon A: Rate of follicular growth in the human ovary.In Follicular Maturation and Ovulation, R Rolland, EV van Hall, SG Hillier, K McNatty, J Schomaker(eds). Amsterdam, Excerpta Medica, 1982, pp 155–163

    Google Scholar 

  6. Hillier SG: Regulation of follicular oestrogen biosynthesis: A survey of current concepts J Endocrinol 1981 ;89:3P-18P

    PubMed  Google Scholar 

  7. Baird DT: A model for follicular selection and ovulation: Lessons from superovulation. J Steroid Biochem 1987:27:15–23

    Article  PubMed  CAS  Google Scholar 

  8. Pantos C, Thornton SJ, Speirs AL, Johnston I: Increasing the human menopausal gonadotrophin dose—Does the response really improve? Fertil Steril 1990:53:436–439

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lashen, H., Ledger, W., Bernal, A.L. et al. Superovulation with a high gonadotropin dose for in vitro fertilization: Is it effective?. J Assist Reprod Genet 15, 438–443 (1998). https://doi.org/10.1007/BF02744938

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02744938

Key words

Navigation